Update: You can find the event report here.
Heart Failure is one of the biggest health threats in Europe. It is the number two reason for hospital admissions, a great individual burden for the patients and a significant economic burden for the health care systems in Europe. Each re-admission to a hospital due to a decompensation of the heart, brings a patient closer to heart transplantation. Early detection, access to all available medical solutions and a better coordination of care along the patient pathway are crucial for the survival of the patients, better quality of life and less financial burden on the health care systems.
Medical devices and In Vitro Diagnostics (IVDs) innovations can be a substantial part of the solution for patients with Chronic Heart Failure and can also help reducing inequality in treatment across Europe.
Join us for a dialogue with experts and patients about their experience and ideas regarding the value of innovations in the field of heart failure. The event - that will be held from 16.30 to 18.30 - will be followed by a networking reception. Please find the detailed programme below.
This event is organised by the European Parliament with the support of MedTech Europe.
This event is open to public and we kindly ask you to register by 21st February with Timea Rezi-Kato (MedTech Europe).
16.00 - 16.30 Registration
16.30 - 16.50 Welcome & Introduction - MEP Aldo Patriciello
16.50 - 17.00 The Heart Failure Policy Network - Ed Harding, Director, The Health Policy Partnership
17.00 - 17.20 Patient perspective - Nick Hartshorne-Evan, Chief Executive of Pumping Marvellous Foundation and President of iHHub - The Global Heart Failure Alliance
17.20 - 18.00 Health professionals’ perspective: From early detection to better coordination - Dr. Paul van Haelst, Senior Medical Director Cardiovascular and Metabolics at Roche Diagnostics &
Prof. Christophe Dubois, University Hospital Leuven, Belgium
18.00 - 18.05 Concluding remarks - MEP Aldo Patriciello
18.05 - 18.30 Discussion & Networking Reception